EN2207 - EN2207: Session 12: Beyond Glycemic Control: Use of Diabetes Medications for Cardiovascular and Renal Indications by Gail Nunlee-Bland, M.D.

Add to Calendar EN2207: Session 12: Beyond Glycemic Control: Use of Diabetes Medications for Cardiovascular and Renal Indications by Gail Nunlee-Bland, M.D. 3/1/2022 12:00:00 AM 2/28/2023 11:00:00 PM America/Los_Angeles For More Details: https://uw.Cloud-CME.com/course/courseoverview?P=0&EID=8331 false MM/DD/YYYY


Date & Location
Tuesday, March 1, 2022, 12:00 AM - Tuesday, February 28, 2023, 11:00 PM, Seattle, WA

Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician (1.00 hours)

Overview

Date of Live Activity: 08/04/2021
Talk Title: Beyond Glycemic Control: Use of Diabetes Medications for Cardiovascular and Renal Indications

Objectives:

  • Enhance knowledge on use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon like peptide 1 receptor agonistGLP-1 RA for cardiac (ASCVD, HF) and renal (CKD, albuminuria) indications “beyond” glycemic management in appropriate populations.
  • Discuss the importance of assessing cardiovascular and renal risk factors in patients with diabetes.
  • Review the cardiovascular outcome trials (CVOT) and renal outcome trials for select GLP-1RAand SGLT-2 inhibitors.
  • Select the appropriate antihyperglycemic agents for cardiovascular and renal risk factors.
  • Identify and select the classes of antihyperglycemic agents, mechanism of action, benefits, and side effects of these agents.

Speaker Name and Credentials: Gail Nunlee-Bland, M.D.; Howard University
Speaker Disclosure(s): Dr. Nunlee-Bland does not have any relationships with ineligible companies to disclose.

Planners Disclosure(s):

  • Nicole Ehrhardt, M.D.: Consultant: Dexcom, NovoNordisk; Educational Grant: NovoNordisk, Merck; Investigator: Dexcom
  • Lorena Wright, M.D.: None
  • Savitha Subramanian, M.D. is on the advisory board for Abbott Diabetes Care.

All relevant financial relationships have been mitigated


Accreditation
Accreditation with Commendation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: The University of Washington School of Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.